MarginsXMarginsX
Home › Canada › CSE stocks › GRIN

Grown Rogue International Inc. (CSE: GRIN)

GRIN trades on the Canadian Securities Exchange in Life Sciences, headquartered in Ontario. Numbers below come from the TMX issuer list, Yahoo Finance closes and the Bank of Canada rate, each with its source.

Close · November 13, 2026
C$0.5200
+9.47% on the day
Market cap (C$)
C$130.0M
TMX list, November 13, 2026
Market cap (US$)
US$91.2M
Micro cap at 1.4257 C$/US$
1-year return
+9.5%
-25.7% year to date

Issuer list, sector and C$ market cap: TMX Group TSX and TSXV listed companies, as of November 13, 2026. US$ figures convert C$ at 1.4257 C$ per US$, the Bank of Canada daily rate for November 13, 2026. Close and returns: Yahoo Finance daily closes for GRIN.CN, last bar 2026-11-13, computed by MarginsX. Website: sociallinks: 10-K text ("our website").

Profile

FieldValue
TickerGRIN on the Canadian Securities Exchange
Yahoo symbolGRIN.CN
SectorLife Sciences, Drug Manufacturers—Specialty & Generic
HeadquartersOntario
ListedThe TMX list gives no listing date
Listing typeTMX leaves listing type blank for long-listed issuers
Shares outstanding249,938,980
Also listed onNo interlisting on the TMX list
Index membershipNot in an S&P/TSX index per the TMX list
SEC CIK0001463000
Websitewww.grownrogue.com

Returns

WindowReturn
1 day+9.5%
1 week+10.6%
1 month-7.1%
3 months-18.8%
6 months+6.1%
Year to date-25.7%
1 year+9.5%
From 52-week high-25.7%
52-week rangeC$0.3800 to C$0.7000

Links

SEDAR+ is linked for searching only; nothing on this page is taken from it.

Recent Canadian filings by type

178 documents in 12 types. Each title links to the document at its source.

Interim financial statements (3)

DocumentTypeFiled
UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE THREE AND SIX MONTInterim financial statements (6-K)2025-08-13
Unaudited Condensed Consolidated Financial Statements
Period 2025-03-31
Interim financial statements (6-K)2025-08-01
Unaudited Condensed Interim Consolidated Financial Statements
Period 2024-09-30
Interim financial statements (6-K)2024-11-15

MD&A (2)

DocumentTypeFiled
FMANAGEMENT DISCUSSION & ANALYSIS FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 20MD&A (interim) (6-K)2025-08-13
MANAGEMENT DISCUSSION & ANALYSIS
Period 2025-03-31
MD&A (interim) (6-K)2025-08-01

Material change report (2)

DocumentTypeFiled
Form 51-102F3Material change report (6-K)2025-04-15
Form 51-102F3Material change report (6-K)2024-11-15

News release (25)

DocumentTypeFiled
NEWS RELEASE DATED NOVEMBER 12, 2026News release (8-K)2026-11-13
NEWS RELEASE DATED OCTOBER 22, 2026News release (8-K)2026-10-23
NEWS RELEASE DATED OCTOBER 20, 2026News release (8-K)2026-10-21
NEWS RELEASE DATED OCTOBER 20, 2026News release (8-K)2026-10-20

Management information circular / proxy (2)

DocumentTypeFiled
DEF 14AProxy statement (DEF 14A)2026-09-04
PRE 14AProxy statement (PRE 14A)2026-08-21

Prospectus (3)

DocumentTypeFiled
PRELIMINARY SHORT FORM BASE SHELF PROSPECTUSProspectus (base shelf) (6-K)2025-04-10
F-1/AProspectus (long form) (F-1/A)2025-02-13
F-1Prospectus (long form) (F-1)2024-12-13

Annual report (3)

DocumentTypeFiled
20-F
Period 2024-12-31
Annual report (20-F) (20-F)2025-04-30
10-K/A
Period 2025-12-31
Annual report (10-K) (10-K/A)2026-05-01
10-K
Period 2025-12-31
Annual report (10-K) (10-K)2026-04-08

Quarterly report (3)

DocumentTypeFiled
10-Q
Period 2026-09-30
Quarterly report (10-Q) (10-Q)2026-11-13
10-Q
Period 2026-06-30
Quarterly report (10-Q) (10-Q)2026-08-05
10-Q
Period 2026-03-31
Quarterly report (10-Q) (10-Q)2026-05-12

Early warning / ownership (4)

DocumentTypeFiled
Schedule 13DSchedule 13D (SCHEDULE 13D)2025-07-01
Schedule 13G amendmentSchedule 13G (SCHEDULE 13G/A)2026-06-08
Schedule 13G amendmentSchedule 13G (SCHEDULE 13G/A)2026-04-17
Schedule 13G amendmentSchedule 13G (SCHEDULE 13G/A)2026-04-15

Insider report (37)

DocumentTypeFiled
Form 3Form 3 (3)2026-06-26
Form 3Form 3 (3)2026-06-26
Form 3Form 3 (3)2026-06-26
Form 3Form 3 (3)2026-06-26

Certification (20)

DocumentTypeFiled
EXHIBIT 32.2
Period 2026-09-30
Certification (SOX 302/906) (10-Q)2026-11-13
EXHIBIT 31.1
Period 2026-09-30
Certification (SOX 302/906) (10-Q)2026-11-13
EXHIBIT 31.2
Period 2026-09-30
Certification (SOX 302/906) (10-Q)2026-11-13
EXHIBIT 32.1
Period 2026-09-30
Certification (SOX 302/906) (10-Q)2026-11-13

Other (74)

DocumentTypeFiled
FORM 8-KCurrent report (8-K) (8-K)2026-11-13
FORM 8-KCurrent report (8-K) (8-K)2026-10-23
FORM 8-KCurrent report (8-K) (8-K)2026-10-21
FORM 8-KCurrent report (8-K) (8-K)2026-10-20

Sources: SEC EDGAR filings (public records). Documents filed only on SEDAR+ are not copied here; search SEDAR+ for the full record.

Trading halts

Trading: the last notice, on 2026-08-21, was a resumption.

NoticeActionReasonNotice
2026-08-21 9:45 AM ETResumptionNo reason statedCIRO notice
2026-08-21 8:38 AM ETHaltPending NewsCIRO notice

Source: Canadian Investment Regulatory Organization (CIRO), Halts/Resumptions newsroom, notices since 2024-10-15.

Upcoming events

No upcoming earnings date, call or meeting announced in the SEC filings and newswire releases we read.

Recent

DateTimeEventWebcastSource
2026-11-125:00 p.m. Eastern TimeQ3 2026 earnings callWebcastSEC filing
2026-11-12after the market closesQ3 2026 earnings releaseNo webcast link announcedSEC filing

Source: dates read from the company's SEC filings and newswire releases; each row links to the announcement.

US private placements (SEC Form D)

FiledSecuritiesSoldOfferedFiling
2023-08-23Equity, Debt, Option To Acquire, Security To Be Acquired, OtherUS$1.0MUS$1.6MSEC EDGAR
2023-07-18Equity, Debt, Option To Acquire, Security To Be Acquired, OtherUS$4.0MUS$6.4MSEC EDGAR
2022-12-12Debt, Option To Acquire, Security To Be Acquired, OtherUS$1.9MUS$3.0MSEC EDGAR
2018-11-29Equity, Option To AcquireUS$22.5MUS$22.5MSEC EDGAR
2012-05-02Equity, OtherUS$750KOpen-endedSEC EDGAR

Source: SEC EDGAR Form D filings matched on SEC CIK. Amounts are US$ as filed.

Peers in Life Sciences

TickerCompanyExchangeMarket cap (C$)1 month1 year
EBMEastwood Bio-Medical Canada Inc.TSXVC$130.9M-7.4%+133.3%
HLSHLS Therapeutics Inc.TSXC$136.2M-8.4%-21.9%
COVCovalon Technologies Ltd.TSXVC$122.3M+3.4%+122.8%
JUSHJushi Holdings Inc.CSEC$111.8M-22.2%-25.3%
MDPMedexus Pharmaceuticals Inc.TSXC$157.9M+12.7%+101.9%

The app has the price chart, every filing, private raises and the full peer set for GRIN.

Open in the app